Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection

Clinical Infectious Diseases

Volumn 61, Issue 4, 2015, Pages 563-571

  Qin, Ying ^a   Horby, Peter W ^b,c,d   Tsang, Tim K ^e   Chen, Enfu ^f   Gao, Lidong ^g   Ou, Jianming ^h   Nguyen, Tran Hien ⁱ   Duong, Tran Nhu ⁱ   Gasimov, Viktor ^j   Feng, Luzhao ^a   Wu, Peng ^e   Jiang, Hui ^a   Ren, Xiang ^a   Peng, Zhibin ^a   Li, Sa ^a   Li, Ming ^a   Zheng, Jiandong ^a   Liu, Shelan ^f   Hu, Shixiong ^g   Hong, Rongtao ^h   Farrar, Jeremy J ^b,c,d,k   Leung, Gabriel M ^e   Gao, George F ^a,l   Cowling, Benjamin J ^e   Yu, Hongjie ^a   more..

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Singapore Infectious Diseases Initiative   (Singapore)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^g Hunan Provincial Center for Disease Control and Prevention   (China)

^h Fujian Provincial Center for Disease Control and Prevention   (China)

ⁱ NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^j Azerbaijan Ministry of Health   (Azerbaijan)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l INSTITUTE OF MICROBIOLOGY   (China)

more..

Author keywords

clinical epidemiology; cluster; influenza A(H5N1); influenza A(H7N9)

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONSANGUINITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INFLUENZA A; INFLUENZA A (H5N1); INFLUENZA A (H7N9); INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N9; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; AGE; AGED; ANIMAL; BASIC REPRODUCTION NUMBER; COMPARATIVE STUDY; FAMILY HEALTH; INFANT; INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H7N9); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; BASIC REPRODUCTION NUMBER; CHILD; CHILD, PRESCHOOL; FAMILY HEALTH; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84933579614     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ345     Document Type: Article

References (37)

1. World Health Organization. Influenza at the Human-Animal Interface. Monthly Risk Assessment Summary. Available at: http://www.who.int/influenza/human-animal-interface/Influenza-Summary-IRA-HA-inter face-6January2015.pdf?ua=1. Accessed 8 January 2015.
2. World Health Organization. WHO risk assessment of human infection with avian influenza A(H7N9) virus. Available at: http://www.who.int/influenza/human-animal-interface/influenza-h7n9/riskassessment- h7n9-2Oct14.pdf?ua=1. Accessed 8 January 2015.
3. Cowling BJ, Jin L, Lau EH, et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 2013; 382:129-37.
4. Centers for Disease Control and Prevention. Influenza Risk Assessment Tool (IRAT). Available at: http://www.cdc.gov/flu/pandemic-resources/tools/risk-assessment.htm. Accessed 8 January 2015.
5. Yu H, Cowling BJ, Feng L, et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet 2013; 382:138-45.
6. Toner ES, Adalja AA, Nuzzo JB, Inglesby TV, Henderson DA, Burke DS. Assessment of serosurveys for H5N1. Clin Infect Dis 2013; 56:1206-12.
7. Wang TT, Parides MK, Palese P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 2012; 335:1463.
8. Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351:467-71.
9. Summary of human infection with highly pathogenic avian influenza A (H5N1) virus reported to WHO, January 2003-March 2009: clusterassociated cases. Wkly Epidemiol Rec 2010; 85:13-20.
10. Li Q, Zhou L, Zhou M, et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med 2014; 370:520-32.
11. Qi X, Qian YH, Bao CJ, et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ 2013; 347:f4752.
12. Horby P, Sudoyo H, Viprakasit V, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect 2010; 138:1550-8.
13. Cauchemez S, Epperson S, Biggerstaff M, Swerdlow D, Finelli L, Ferguson NM. Using routine surveillance data to estimate the epidemic potential of emerging zoonoses: application to the emergence of US swine origin influenza A H3N2v virus. PLoSMed 2013; 10:e1001399.
14. Ma MJ, Ma GY, Yang XX, et al. Avian influenza A(H7N9) virus antibodies in close contacts of infected persons, China, 2013-2014. Emerg Infect Dis 2015; 21:709-11.
15. Yang S, Chen Y, Cui D, et al. Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study. J Infect Dis 2014; 209:265-9.
16. Wang X, Fang S, Lu X, et al. Seroprevalence to avian influenza A(H7N9) virus among poultry workers and the general population in southern China: a longitudinal study. Clin Infect Dis 2014; 59:e76-83.
17. Van Kerkhove MD, Riley S, Lipsitch M, et al. Comment on Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 2012; 336:1506; author reply.
18. Aditama TY, Samaan G, Kusriastuti R, et al. Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia. Clin Infect Dis 2011; 53:1237-44.
19. Horby P, Nguyen NY, Dunstan SJ, Baillie JK. The role of host genetics in susceptibility to influenza: a systematic review. PloS One 2012; 7: e33180.
20. Horby P, Nguyen NY, Dunstan SJ, Baillie JK. An updated systematic review of the role of host genetics in susceptibility to influenza. Influenza Other Respi Viruses 2013; 7(suppl 2):37-41.
21. Lin TY, Brass AL. Host genetic determinants of influenza pathogenicity. Curr Opin Virol 2013; 3:531-6.
22. Juno J, Fowke KR, Keynan Y. Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses. Clin Dev Immunol 2012; doi:10.1155/2012/797180.
23. Mubareka S, Palese P. Human genes and influenza. J Infect Dis 2008; 197:1-3.
24. Trammell RA, Toth LA. Genetic susceptibility and resistance to influenza infection and disease in humans and mice. Expert Rev Mol Diagn 2008; 8:515-29.
25. Zhang L, Katz JM, Gwinn M, Dowling NF, Khoury MJ. Systems-based candidate genes for human response to influenza infection. Infect Genet Evol 2009; 9:1148-57.
26. Keynan Y, Juno J, Meyers A, et al. Chemokine receptor 5?32 allele in patients with severe pandemic (H1N1) 2009. Emerg Infect Dis 2010; 16:1621-2.
27. Chan JF, To KK, Tse H, et al. The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation. Clin Vaccine Immunol 2011; 18:305-10.
28. Ferdinands JM, Denison AM, Dowling NF, et al. A pilot study of host genetic variants associated with influenza-associated deaths among children and young adults. Emerg Infect Dis 2011; 17:2294-302.
29. Antonopoulou A, Baziaka F, Tsaganos T, et al. Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection. Int J Infect Dis 2012; 16: e204-8.
30. Everitt AR, Clare S, Pertel T, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012; 484:519-23.
31. Zuniga J, Buendia-Roldan I, Zhao Y, et al. Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J 2012; 39:604-10.
32. Hertz T, Oshansky CM, Roddam PL, et al. HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection. Proc Natl Acad Sci U S A 2013; 110:13492-7.
33. Zhang YH, Zhao Y, Li N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 2013; 4:1418.
34. To KK, Zhou J, Song YQ, et al. Surfactant protein B gene polymorphism is associated with severe influenza. Chest 2014; 145:1237-43.
35. Wang Z, Zhang A,Wan Y, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A 2014; 111:769-74.
36. Wang C, Yu H, Horby PW, et al. Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis 2014; 58:1095-103.
37. Antia R, Regoes RR, Koella JC, Bergstrom CT. The role of evolution in the emergence of infectious diseases. Nature 2003; 426:658-61.